Cargando…
Night‐time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole
AIMS: Nocturnal acid breakthrough has been considered an unmet need of proton‐pump inhibitors. Tegoprazan, a novel potassium‐competitive acid blocker, is expected to show improved properties for this unmet need. This study was aimed to compare night‐time acid suppression by tegoprazan with that by v...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305887/ https://www.ncbi.nlm.nih.gov/pubmed/35146797 http://dx.doi.org/10.1111/bcp.15268 |